Search Clear
We provide a full range of legal services to the investment community including the establishment and marketing of funds, the making of investments and structuring of private equity and venture deals. We also advise in connection with acquisition financing and buy-outs. We represent clients in all phases of their venture capital and private equity activities, including seed capital, first and later rounds of funding, debt financing, trade sales, initial public offerings and follow-on offerings.
We have particular strength in relation to private equity and venture capital financing transactions for companies in the life sciences, technology, and media and telecommunications sectors.
We also have significant strength in cross-border transactions. Our work is usually international in nature and U.S. and UK qualified lawyers in the European practice work closely with attorneys from our 16 offices worldwide.
Matters
• on its $10m Series B investment into Orchard Therapeutics. Orchard Therapeutics is a privately-held clinical-stage biotechnology company based in the UK and in California, US.
Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.